Company: SINT
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021930
Chunk: 31

Company: Sintx Technologies, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 8
Chunk 31
---

The
following table summarizes, for the periods indicated, cash flows from operating, investing and financing activities (in thousands) –
unaudited:

    Nine Months Ended September 30, 

    2025  
    2024 
  
    Net cash used in operating activities 
    $(6,227) 
    $(7,518)
  
    Net cash provided by (used in) investing activities 
     955  
     (204)
  
    Net cash provided by financing activities 
     7,924  
     9,196 
  
    Net increase in cash 
    $2,652  
    $1,474 

21

Net
cash used in operating activities

Net
cash used in operating activities was $6.2 million during the nine months ended September 30, 2025, compared to $7.5 million used
during the nine months ended September 30, 2024, a decrease of $1.3 million. Decrease in net loss of $1.2 million, combined with an
increase in accounts payables and other liabilities of $1.0 million, contributed positively to our net cash used in operating
activities, partially offset by a decrease in adjustments of non-cash items of $0.5 million, and increases in accounts receivable of
$0.4 million.

Net
cash provided by (used in) investing activities

Net
cash provided by investing activities was $1.0 million during the nine months ended September 30, 2025, compared to net cash used in
investing activities of $0.2 million during the nine months ended September 30, 2024, an increase of $1.2 million. The increase in cash
provided by investing activities during 2025 was primarily due to $0.8 million in proceeds from the acquisition of Sinaptic Surgical
(see Note 3), $0.4 million decrease in purchase of property and equipment and $0.3 million increase in proceeds from the sale of property
and equipment, partially offset by a $0.3 million decrease in proceeds from notes receivable.

Net
cash provided by financing activities

Net
cash provided by financing activities was $7.9 million during the nine months ended September 30, 2025, compared to $9.2 million
provided during the same period in 2024. The $1.3 million decrease to net cash provided by financing activities was primarily